Abstract | BACKGROUND: RESULTS: In this study, using novel monoclonal antibody-based in-house enzyme-linked immunosorbent assay systems, we report the absolute quantification of HBZ protein and its plasma antibody in clinical samples from HTLV-1-infected individuals with different clinical status. The data were compared to both HBZ mRNA levels and PVL. The results showed that plasma anti-HBZ antibody was detectable only in 10.4 % (5/48) of asymptomatic carriers (ACs), 10.8 % (13/120) of HAM/TSP patients, and 16.7 % (7/42) of ATL patients. HBZ protein was detected in three out of five patients with acute ATL, but was not detected in patients with HAM/TSP (0/10) or ACs (0/4). Thus, an antibody response to HBZ was not associated with the PVL or the expression of HBZ (both at the mRNA and protein levels) or the clinical status of the infection. CONCLUSIONS: The present results emphasize the extremely low expression and immunogenicity of HBZ in natural HTLV-1 infection. However, there is a possibility that the low but distinct expression of HBZ protein in PBMCs is associated with the survival of HTLV-1-infected cells and the development of ATL.
|
Authors | Yasuo Shiohama, Tadasuke Naito, Toshio Matsuzaki, Reiko Tanaka, Takeaki Tomoyose, Hiroshi Takashima, Takuya Fukushima, Yuetsu Tanaka, Mineki Saito |
Journal | Retrovirology
(Retrovirology)
Vol. 13
Pg. 29
(Apr 27 2016)
ISSN: 1742-4690 [Electronic] England |
PMID | 27117327
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Basic-Leucine Zipper Transcription Factors
- HBZ protein, human T-cell leukemia virus type I
- RNA, Messenger
- RNA, Viral
- Retroviridae Proteins
|
Topics |
- Adult
- Antibodies, Viral
(blood)
- Basic-Leucine Zipper Transcription Factors
(blood)
- Enzyme-Linked Immunosorbent Assay
- Female
- HTLV-I Infections
(immunology, pathology, virology)
- Humans
- Male
- Middle Aged
- Plasma
(chemistry)
- RNA, Messenger
(blood)
- RNA, Viral
(blood)
- Retroviridae Proteins
(blood)
- Viral Load
|